Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
FBIO
Fortress Biotech, Inc.
NASDAQCM
Biotechnology
United States
$2.72
▲
+0.00 (+0.18%)
OPEN
—
OPEN
$2.68
HIGH
$2.74
LOW
$2.68
PREV CLOSE
$2.71
VOLUME
141.3K
0.24x avg
BID / ASK
1.95 / 3.46
spr 1.510
MARKET CAP
$90.5M
DAY RANGE
$2.68
$2.74
P/E (TTM)
0.98
Fwd -1.5
EPS (TTM)
2.77
DIV YIELD
—
52W HIGH
$4.53
-40.1%
52W LOW
$2.18
+24.5%
BETA
1.19
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
PRE-MARKET
$2.74
+0.03
(+1.11%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
FBIO
$2.72
▲
+0.18%
Chart
Valuation
Financials
Peers
News
FBIO · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
Loading K-line chart…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
MIXED
253 BARS · -4.4% YOY
1-year price chart. Started at 2.84, currently 2.71, down 4.4 percent. Range 2.22 to 4.38 over 253 data points.
2025-09-04
$2.84 → $2.71 (-4.4%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$103.77
WACC Used
+7.0%
Terminal g
+3.5%
Verdict: strong-buy
· peers $103.77 (+3722.0%)
Peers:
ANIX
ATRA
PTHS
HSTC
ACET
ACRV
ICCC PE141
RLYB PE2
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
RISK-ON
YOY REV +11.1% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$61.2M
$6.8M
-$65.8M
—
$185.5M
2024-12
$55.1M
-$46.0M
-$80.2M
-$80.2M
$144.2M
2023-12
$59.7M
-$60.6M
-$128.2M
-$128.3M
$167.5M
PEERS
Sector & Industry Peers
CALM
10 PEERS · FINNHUB
ANIX
ATRA
PTHS
HSTC
ACET
ACRV
ICCC
RLYB
ALDX
OSTX
NEWS
Recent News (past 14 days)
CALM
9 HEADLINES · LAST 14 DAYS
Fortress Biotech, Inc. Q2 2026 Earnings Call Summary
Moby · 2026-08-14
Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript
Motley Fool · 2026-08-14
Fortress Biotech: Q2 Earnings Snapshot
Associated Press · 2026-08-13
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · 2026-08-13
Fortress Biotech Q2 Earnings Call Highlights
MarketBeat · 2026-08-12
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · 2026-08-12
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
GlobeNewswire · 2026-08-05
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
GlobeNewswire · 2026-07-27